Since January 2016, MTEC has worked to accelerate the development of medical solutions that prevent and treat injuries and restore America's military and veterans to full health.
The Army’s Medical Technology Enterprise Consortium aims to accelerate the advancement of noninvasive hemorrhage detection technology. According to the MTEC, hemorrhage, or life-threatening blood loss, has accounted for more than 33% of prehospital deaths and 50% of deaths occurring within 24 hours after a traumatic injury.
“It’s been exciting to watch the use of OTAs grow and expand at USAMRDC over the past few years,” said Sara Langdon, the command’s program manager (PM) for other-transactions with the Medical Technology Enterprise Consortium. “The flexibility has allowed for awards that involve complex collaborations with multiple companies and government laboratories, in addition to several acquisition programs.”
The Medical Technology Enterprise Consortium (MTEC) uses a first-of-its-kind funding mechanism that enables both the government and private sponsors to support groundbreaking medical research.
ATI announced that it has received a 6-month award from the U.S. Army Medical Research and Materiel Command (USAMRMC) to organize a new Medical Technology Enterprise Consortium (MTEC).